AI assistant
Sending…
Crinetics Pharmaceuticals, Inc. — Director's Dealing 2020
Sep 3, 2020
31156_dirs_2020-09-03_09e8da11-9dfb-4d07-a1f1-c8ce2b6499d1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Crinetics Pharmaceuticals, Inc. (CRNX)
CIK: 0001658247
Period of Report: 2020-09-01
Reporting Person: Bedrosian Camille L (Director)
More from Crinetics Pharmaceuticals, Inc.
Board/Management Information
2026
Mar 23
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Audit Report / Information
2026
Mar 3
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25